Publications by authors named "Maria-Helena Garcia-Sanchez"

Urinary tract infections affect more than 50% of women. 25% derive from recurrent UTI (RUTI). It is not known the relationship between obstetric history and RUTI occurrence.

View Article and Find Full Text PDF

Objectives: to demonstrate the benefits of physiotherapy (PT) with pelvic floor biofeedback (BFB) in improving health-related quality of life when used as a complementary therapy after surgical treatment of cystocele, in cases in which perineal pain or discomfort persists.

Materials And Methods: prospective observational study in 226 women who received complementary therapy after surgical treatment of cystocele due to persistent perineal discomfort or pain. Groups: GA ( = 78): women treated with 25 mg of oral pregabalin every 12 h plus BFB, consisting of 20 once-weekly therapy sessions, each 20 min long, with perineal pregelled surface electrodes connected to a screen which provides visual feedback; GB ( = 148): women treated with oral pregabalin 25 mg every 12 h without BFB.

View Article and Find Full Text PDF

Rationale: This report describes a Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis.

Patient Concerns: We present a 31-year-old Caucasian nulliparous patient who was admitted as an emergency with general illness status accompanied by holocranial cephalalgia and fever.

Diagnoses: The previous symptoms were followed by disorientation, persecutory delusion, incoherent language, and tonic-clonic seizure.

View Article and Find Full Text PDF

Background: Few studies have evaluated the risk of pregnancy-related adverse events in asymptomatic relatives of probands for VTE and factor V Leiden or the G20210A variant. The antepartum management of this population ranges from antepartum anticoagulation therapy to clinical surveillance.

Objective: To evaluate the risk of placenta-mediated pregnancy complications and pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and who are heterozygous carriers of either factor V Leiden or PT-G20210A mutation.

View Article and Find Full Text PDF